Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

A Phase I/II Trial of Intravenous Azacitidine for Acute Gvhd Prophylaxis in Patients Undergoing Matched Unrelated Stem Cell Transplantation: Phase I Results

Mark A. Schroeder, MD, Jaebok Choi, PhD, Matthew L Cooper, PhD, David Schwab, BA CCRP, Sarah Willey, Jingxia (Esther) Liu, PhD, Matthew Holt, Linda Eissenberg, Iskra Pusic, MD, Armin Ghobadi, MD, Rizwan Romee, MD, John S. Welch, MD PhD, Keith Stockerl-Goldstein, MD, Camille N. Abboud, MD FACP, Ravi Vij, MD, Geoffrey L. Uy, MD, Peter Westervelt, MD PhD, John F Dipersio, MD PhD

Blood (2015) 126 (23): 1935.

https://doi.org/10.1182/blood.V126.23.1935.1935

Published: 2015

Journal Articles

A Phase I Study of Vosaroxin Plus Azacitidine for Patients with Myelodysplastic Syndrome

Meagan A. Jacoby, MD PhD, Camille N. Abboud, MD FACP, John F Dipersio, MD PhD, Amanda F. Cashen, MD, Matthew J. Walter, MD, Rigoberto De Jesus Pizarro, Geoffrey L. Uy, MD

Blood (2015) 126 (23): 1686.

https://doi.org/10.1182/blood.V126.23.1686.1686

Published: 2015

Journal Articles

Addition of Mycophenolate Mofetil to Methotrexate and Tacrolimus Does Not Improve Gvhd Outcomes in Reduced Intensity Allogeneic Hematopoietic Cell Transplantation

Se young Han, MD, Pavan Kumar Bhamidipati, MBBS,MD, Khoan Vu, MD, John F Dipersio, MD PhD, Feng Gao, PhD, Iskra Pusic, MD, Geoffrey L. Uy, MD, Peter Westervelt, MD PhD, Ravi Vij, MD, Mark A. Schroeder, MD, Camille N. Abboud, MD FACP, Keith Stockerl-Goldstein, MD, Amanda F. Cashen, MD, Todd A Fehniger, MD PhD, Rizwan Romee, MD

Blood (2015) 126 (23): 3144.

https://doi.org/10.1182/blood.V126.23.3144.3144

Published: 2015

Journal Articles

Use of Post-Transplant Cyclophosphamide (PTCy) with Mycophenolate Mofetil and Tacrolimus in HLA Matched Allogeneic Hematopoietic Cell Transplant Is Safe and Associated with Acceptable Transplant Outcomes

Brian T Hess, MD, Feng Gao, PhD, John F. DiPersio, MD PhD, Peter Westervelt, MD PhD, Ravi Vij, MD, Geoffrey L. Uy, MD, Keith Stockerl-Goldstein, MD, Camille N. Abboud, MD FACP, Mark A. Schroeder, MD, Iskra Pusic, MD, Armin Ghobadi, MD, Amanda F. Cashen, MD, Todd A Fehniger, MD PhD, Meagan A. Jacoby, MD PhD, Rizwan Romee, MD

Blood (2015) 126 (23): 1950.

https://doi.org/10.1182/blood.V126.23.1950.1950

Published: 2015

Journal Articles

Dynamic Changes in Clonal Clearance with Decitabine Therapy in AML and MDS Patients

Blood (2015) 126 (23): 689.

https://doi.org/10.1182/blood.V126.23.689.689

Published: 2015

Journal Articles

T-Cell Replete Peripheral Blood Haploidentical Donor Transplant Is Frequently Associated with Cytokine Release Syndrome Which Responds to Anti-IL-6 Therapy

Ramzi Abboud, MD, Jesse Keller, MD, Michael Slade, BA, Michael P. Rettig, PhD, Stephanie Meier, John F. DiPersio, MD PhD, Todd A Fehniger, MD PhD, Kathryn Trinkaus, Geoffrey L. Uy, MD, Peter Westervelt, MD PhD, Ravi Vij, MD, Camille N. Abboud, MD FACP, Khoan Vu, MD, Pavan Kumar Bhamidipati, MBBS,MD, Rizwan Romee, MD

Blood (2015) 126 (23): 3106.

https://doi.org/10.1182/blood.V126.23.3106.3106

Published: 2015

Journal Articles

Chemotherapy Versus Hypomethylating Agents for the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome Following Allogeneic Stem Cell Transplant: A Retrospective Review

Ibraheem H Motabi, MD, Jingxia Liu, PhD, Camille N. Abboud, MD FACP, Amanda F. Cashen, MD, Keith E. Stockler-Goldstein, MD, Geoffrey L. Uy, MD, Ravi Vij, MD, Peter Westervelt, MD PhD, John F. DiPersio

Blood (2014) 124 (21): 3944.

https://doi.org/10.1182/blood.V124.21.3944.3944

Published: 2014

Journal Articles

Prognostic Significance of PET Imaging in Relapsed or Refractory Classical Hodgkin Lymphoma Treated with Salvage Chemotherapy and Autologous Stem Cell Transplantation.

Jacob Smeltzer, MD, Amanda F Cashen, MD, Qin Zhang, MS, Camille N. Abboud, MD, FACP, John F. DiPersio, MD, PhD, Keith Stockerl-Goldstein, MD, Geoffrey L. Uy, MD, Ravi Vij, MD, Peter Westervelt, MD, PhD, Nancy L Bartlett, MD, Todd A Fehniger, MD, PhD,

Blood (2009) 114 (22): 3417.

https://doi.org/10.1182/blood.V114.22.3417.3417

Published: 2009

Journal Articles

Busulfan/Fludarabine/Thymoglobulin as a Reduced Intensity Conditioning Regimen for Lymphoid Malignancies.

Jeevan Sekhar, Keith Stockerl-Goldstein, Qin Zhang, MS, Amanda F Cashen, MD, Camille N. Abboud, MD, FACP, Geoffrey L. Uy, MD, Peter Westervelt, MD, PhD, John F. DiPersio, MD, PhD, Ravi Vij, MD

Blood (2009) 114 (22): 3335.

https://doi.org/10.1182/blood.V114.22.3335.3335

Published: 2009

Journal Articles

Phase-2 Study of Pomalidomide in Advanced Corticosteroid-Resistant Chronic Graft-Versus-Host Disease (cGVHD).

Iskra Pusic, MD, John F. DiPersio, MD, PhD, Stefanie L Goran, MD, Edie M Romvari, FNP, Stephanie L Bauer, FNP, Holly S Comer, FNP, Camille N. Abboud, MD, FACP, Amanda F Cashen, MD, Robert Peter Gale, MD, PhD, DSc, Steven Z. Pavletic, MD

Blood (2009) 114 (22): 3326.

https://doi.org/10.1182/blood.V114.22.3326.3326

Published: 2009

Journal Articles

Allogeneic Stem Cell Transplantation Conditioning for MDS and AML with Clofarabine, Cytarabine and ATG

Michael G. Martin, MD, Geoffrey L. Uy, MD, Elizabeth Procknow, Keith Stockerl-Goldstein, MD, Amanda F. Cashen, MD, Peter Westervelt, MD, PhD, Camille N. Abboud, MD, FACP, Kristan Augustin, PharmD, Jingqin Luo, John F. DiPersio, MD, PhD, Ravi Vij, MD

Blood (2008) 112 (11): 4427.

https://doi.org/10.1182/blood.V112.11.4427.4427

Published: 2008

Journal Articles

Cladribine in the Treatment of Acute Myeloid Leukemia

Michael G. Martin, MD, John S. Welch, MD, PhD, Kristan Augustin, PharmD, Lindsay Hladnik, PharmD, Camille N. Abboud, MD, FACP

Blood (2008) 112 (11): 4032.

https://doi.org/10.1182/blood.V112.11.4032.4032

Published: 2008

Journal Articles

Superiority of Rasburicase Versus Allopurinol on Serum Uric Acid Control in Adult Patients with Hematological Malignancies at Risk of Developing Tumor Lysis Syndrome : Results of a Randomized Comparative Phase III Study.

Jorge Cortes, MD, Karen Seiter, MD, Richard Thomas Maziarz, MD, Meir Wetzler, MD, Michael Craig, MD, Jeffrey Matous, Selina Luger, MD, Bimalangshu Dey, MD, Gary J. Schiller, MD, FACP, Dat Pham, MD, Camille N. Abboud, MD, FACP, Muthuswamy Krishnamurthy, MD, Archie Brown, Jr., MD, Joseph O. Moore, MD

Blood (2008) 112 (11): 919.

https://doi.org/10.1182/blood.V112.11.919.919

Published: 2008

NARROW

A Phase I/II Trial of Intravenous Azacitidine for Acute Gvhd Prophylaxis in Patients Undergoing Matched Unrelated Stem Cell Transplantation: Phase I Results

A Phase I Study of Vosaroxin Plus Azacitidine for Patients with Myelodysplastic Syndrome

Addition of Mycophenolate Mofetil to Methotrexate and Tacrolimus Does Not Improve Gvhd Outcomes in Reduced Intensity Allogeneic Hematopoietic Cell Transplantation

Use of Post-Transplant Cyclophosphamide (PTCy) with Mycophenolate Mofetil and Tacrolimus in HLA Matched Allogeneic Hematopoietic Cell Transplant Is Safe and Associated with Acceptable Transplant Outcomes

Dynamic Changes in Clonal Clearance with Decitabine Therapy in AML and MDS Patients

T-Cell Replete Peripheral Blood Haploidentical Donor Transplant Is Frequently Associated with Cytokine Release Syndrome Which Responds to Anti-IL-6 Therapy

Chemotherapy Versus Hypomethylating Agents for the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome Following Allogeneic Stem Cell Transplant: A Retrospective Review

Prognostic Significance of PET Imaging in Relapsed or Refractory Classical Hodgkin Lymphoma Treated with Salvage Chemotherapy and Autologous Stem Cell Transplantation.

Busulfan/Fludarabine/Thymoglobulin as a Reduced Intensity Conditioning Regimen for Lymphoid Malignancies.

Phase-2 Study of Pomalidomide in Advanced Corticosteroid-Resistant Chronic Graft-Versus-Host Disease (cGVHD).

Allogeneic Stem Cell Transplantation Conditioning for MDS and AML with Clofarabine, Cytarabine and ATG

Cladribine in the Treatment of Acute Myeloid Leukemia

Superiority of Rasburicase Versus Allopurinol on Serum Uric Acid Control in Adult Patients with Hematological Malignancies at Risk of Developing Tumor Lysis Syndrome : Results of a Randomized Comparative Phase III Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only